Development and characterization of oleic acid vesicles for the topical delivery of fluconazole

References

• Agarwal, R., Katare, O.P., Vyas, S.P. (2001). Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 228:43–52.
   PubMed Web of Science ®Google Scholar
• Apel, C.L., Deamer, D.W., Mautner, M.N. (2002). Self-assembled vesicles of monocarboxylic acids and alcohols: conditions for stability and for the encapsulation of biopolymers. Biochim Biophys Acta. 1559:1–9.
   PubMed Web of Science ®Google Scholar
• Aungst, B.J. (1989). Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants. Pharm Res. 6:244–55.
   PubMed Web of Science ®Google Scholar
• Azeem, A., Jain, N., Iqbal, Z., Ahmad, F.J., Aqil, M., Talegaonkar, S. (2008). Feasibility of proniosomes-based transdermal delivery of frusemide:formulation optimization and pharmacotechnical evaluation. Pharm Dev Technol. 13:155–63.
   PubMed Web of Science ®Google Scholar
• Bhatia, A.K., Kumar, R., Katare, O.P. (2004). Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci. 7:252–9.
   PubMed Web of Science ®Google Scholar
• Boinpally, R.R., Zhou, S.L., Poondru, S., Devraj, G., Jasti, G.R. (2003). Lecithin vesicles for topical delivery of diclofenac. Eur J Pharm Biopharm. 56:389–92.
   PubMed Web of Science ®Google Scholar
• Bouwstra, J.A., Honeywell-Nguyen, P.L., Gooris, G.S., Ponec, M. (2003). Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res. 42:1–36.
   PubMed Web of Science ®Google Scholar
• Bouwstra, J.A., Ponec, M. (2006). The skin barrier in healthy and diseased state. Biochim Biophys Acta. 1758:2080–95.
   PubMed Web of Science ®Google Scholar
• Choppin, P.W., Roos, D.S. (1985). Biochemical studies on cell fusion. II Control of fusion response by lipid alteration. J Cell Biol. 101:1591–8.
   PubMed Web of Science ®Google Scholar
• Cistola, D.P., Hamilton, J.A., Jackson, D., Small, D.M. (1988). Ionization and phase behaviour of fatty acids in water: application of the Gibbs phase rule. Biochemistry. 27:1881–8.
   PubMed Web of Science ®Google Scholar
• Creutz, C.E. (1981). Cis-unsaturated fatty acids induce fusion of chromaffin granules aggregated by synexin. J Cell Biol. 91:247–56.
   PubMed Web of Science ®Google Scholar
• Dowling, M.B., Lee, J.H., Raghavan, S.R. (2009). pH-Responsive jello: gelatin gels containing fatty acid vesicles. Langmuir. 25:8519–25.
   PubMed Web of Science ®Google Scholar
• Ecobichon, D.J. (1997). The basics of toxicity testing. New York: CRC.
   Google Scholar
• El laithy, H.M., El-Shaboury, K.M.F. (2002) The development of cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS PharmSciTech. 3:1–9.
   Google Scholar
• Faergemann, J., Laufen, H. (1993). Levels of fluconazole in serum, stratum correum, epidemis-dermis (without stratum correum) and ecrine sweet. Clin Exp Dermatol. 18:102–6.
   PubMed Web of Science ®Google Scholar
• Gebicki, J.K., Hicks, M. (1973). Ufasomes are stable particles surrounded by unsaturated fatty acid membranes. Nature. 243:232–4.
   PubMed Web of Science ®Google Scholar
• Gillet, A., Grammenos, A., Compère, P., Evrard, B., Piel, G. (2009). Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome. Int J Pharm. 380:174–80.
   PubMed Web of Science ®Google Scholar
• Hargreaves, W.R., Deamer, D.W. (1978). Liposomes from ionic, single chain amphiphiles. Biochemistry. 17:3759–68.
   PubMed Web of Science ®Google Scholar
• Hathout, R., Mansour, S., Mortada, N.D., Guinedi, A.S. (2007). Liposomes as ocular delivery system for acetzolamide: in vitro and in vivo studies. AAPS Pharm Sci Tech. 8:E1–2.
   PubMed Web of Science ®Google Scholar
• Higuchi, W.I. (1962). Analysis of data on the medicament release from ointments. J Pharm Sci. 51:802–4.
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen, P.L., Bouwstra, J.A. (2005). Vesicles as a tool for transdermal and dermal testing. Drug Discov Today. 2:67–74.
   Google Scholar
• Kanikkannan, N., Kandimalla, K., Lamba, S.S., Singh, M. (2000). Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem. 7:593–608.
   PubMed Web of Science ®Google Scholar
• Kaushik, D., Batheja, P., Kilfoyle, B., Rai, V., Michniak-Kohn, B. (2008). Percutaneous permeation modifiers: enhancement versus retardation. Expert Opin Drug Deliv. 5:517–29.
   PubMed Web of Science ®Google Scholar
• Kim, M.K., Chung, S.K., Lee, M.H., Cho, A.K., Shim, C.K. (1997). Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel. J Contr Rel. 46:243–51.
   Web of Science ®Google Scholar
• Klimke, K., Schäfer-Korting, M. (1997). Effect of keratin on the efficacy of fluconazole. Mycoses. 40:43–6.
   PubMed Web of Science ®Google Scholar
• López-Pinto, J.M., González-Rodríguez, M.L., Rabasco, A.M. (2005). Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm. 298:1–12.
   PubMed Web of Science ®Google Scholar
• Luisi, P.L., Walde, P., Blocher, M., Blochliger, E. (1998). Matrix effect in the size distribution of fatty acid vesicles. J Phys Chem B. 102:10383–90.
   Web of Science ®Google Scholar
• Marly, E.M.J., Kuijk-Meuwissen, V., Mougin, L., Junginger, H.E., Bouwstra, J.A. (1998). Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study. J Contr Rel. 56:189–96.
   PubMed Web of Science ®Google Scholar
• Murakami, M.Y. (1996). Effect of oleic acid vesicles on intestinal absorption of carboxyfluorescein in rats. Pharm Res. 3:35–41.
   Google Scholar
• Mutalik, S., Udupa, N. (2004). Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci. 93:1577–94.
   PubMed Web of Science ®Google Scholar
• Naik, A., Pechtold, L., Potts, R.O., Guy, H.R. (1995). Mechanism of oleic acid-induced skin penetration enhancement. J Contr Rel. 35:299–306.
   Google Scholar
• Nasr, M., Mansoor, S., Mortada, M.D., Elshamy, A.A. (2008). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul. 25:499–512.
   PubMed Web of Science ®Google Scholar
• Prestegard, J.H., Kantor, H.L. (1975). Fusion of fatty acid containing lecithin vesicles. Biochemistry. 14:1790–5.
   PubMed Web of Science ®Google Scholar
• Robinson, B.H., Walde, P., Rogerson, M.L., Bucak, S. (2006). Kinetic studies of the interaction of fatty acids with phosphatidylcholine vesicles (liposomes). Colloids Surf B Biointerfaces. 48:24–34.
   PubMed Web of Science ®Google Scholar
• Sharma, B.B., Jain, S.K., Vyas, S.P. (1994). Topical liposomal system bearing local anesthetic lignocaine. J Microencapsul. 11:229–86.
   Google Scholar
• Singh, M.S. (1993). Preparation of liposomal fluconazole and their in-vitro antifungal activity. J Microencapsul. 10:229–36.
   PubMed Web of Science ®Google Scholar
• Singh, R., Vyas, S.P. (1996). Topical liposomal system for localized and controlled drug delivery. J Dermatol Sci. 13:107–11.
   PubMed Web of Science ®Google Scholar
• Sinico, C., Fadda, A.M. (2009). Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv. 6:813–25.
   PubMed Web of Science ®Google Scholar
• Thewalt, J.L., Rowat, A.C., Kitson, N. (2006). Interactions of oleic acid and model stratum corneum membranes as seen by 2H NMR. Int J Pharm. 307:225–31.
   PubMedGoogle Scholar
• Vavrova, K., Zbytovska, J., Hrabalek, A. (2005). Amphiphilic transdermal permeation enhancers: structure-activity relationships. Curr Med Chem. 12:2273–91.
   PubMed Web of Science ®Google Scholar
• Walde, P., Namani, T., Morigaki, K., Hauser, H. (2007). Formation and properties of fatty acid vesicles (liposomes). In: Gregoriadis, G., ed. Liposome technology. 3rd ed. New York: Informa Healthcare, 1–20.
   Google Scholar
• Wattananat, T., Akarawut, W. (2006). Validated HPLC method for the determination of fluconazole in human plasma. Biomed Chromatogr 20:1–3.
   PubMed Web of Science ®Google Scholar
• Wildfeuer, A., Faergemann, J., Laufen, H., Pfaff, G., Zimmermann, T., Seidl, H.P., Lach, P. (1994). Bioavailability of fluconazole in the skin after oral medication. Mycoses. 37:127–30.
   PubMed Web of Science ®Google Scholar
• Williams, A. (2003). Transdermal and topical drug delivery. 1st ed. London, UK: Pharmaceutical Press.
   Google Scholar
• Yamaguchi, Y., Nagasawa, T., Nakamura, N., Takenaga, M., Mizoguchi, M., Kawai, S., Mizushima, Y., Igarashi, R. (2005). Successful treatment ofphoto-damaged skin of nano-scale atRA particles using a novel transdermal delivery. J Contr Rel. 104:29–40.
   PubMed Web of Science ®Google Scholar
• Zao, S.S., Du, Q., Cao, D.Y. (2007). Preparation of liposomal fluconazole gel and in vitro transdermal delivery. J Chin Pharm Sci. 16:116–8.
   Google Scholar